AGC Biologics Partners with Novelty Nobility for Cell Line Development and Phase I Preparations of Antibody Drug Candidate
Global CDMO supports South Korean company on a multiphase project at its Copenhagen and Chiba sites COPENHAGEN, Denmark & CHIBA, Japan–(BUSINESS WIRE)–AGC Biologics, your friendly CDMO expert, today announced a multiphase partnership with Novelty Nobility Inc., a clinical-stage biotech company based in South Korea. Novelty Nobility will leverage AGC Biologics’ expertise and proprietary CHEF1® expression … [Read more…]